Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Preliminary phase II results presented for VAC-3S HIV vaccine

July 29, 2015

Prevention of HIV transcription from latency by Tat inhibitor

July 23, 2015

FDA grants breakthrough therapy designation to BMS-663068

July 22, 2015

European Commission approves Evotaz for HIV-1 infection in adults

July 17, 2015

CytoDyn reports evidence of HIV suppression with PRO-140

July 16, 2015

McGill University patents anti-GD cancer vaccine

July 6, 2015

NIH grant supports GeoVax's clade C HIV vaccine development program

July 6, 2015

Gilead submits NDA for emtricitabine/rilpivirine/tenofovir alafenamide in HIV

July 2, 2015

MK-1439A enters two new phase III studies in HIV

July 2, 2015

CytoDyn starts first phase III trial of PRO-140 in HIV infection

June 10, 2015

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...